SLC5A2 and endothelial dysfunction: The purpose of this study was to investigate the hypothesis that inhibition of SGLT2 by ipragliflozin ameliorates endothelial dysfunction and vascular inflammation by inhibiting oxidative stress in STZ-induced diabetic mice.